UK’s EnsiliTech bags £4.5m to make vaccines stable at room temperature
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Kitchener, ON – October 10, 2023: FluidAI Medical (FluidAI), a pioneer in leveraging artificial intelligence (AI) for postoperative patient monitoring, today announced that it has raised $15 million in Series A funding, led by SOSV and Graphene Ventures with participation from Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital, Kyto Technology & Life Science […] The post FluidAI Medical Announces $15M in Series A Funding for AI-Driven Postoperative Monitor at HLTH 202...| FluidAI Medical
Kitchener, ON – September 14, 2023: FluidAI Medical, a leading artificial intelligence (AI) startup and developer of the Stream™ Platform for post-surgical monitoring, has announced a strategic partnership with Medtronic Canada ULC, a prominent subsidiary of the global healthcare technology company, Medtronic PLC. Together, they are working to revolutionize Canadian healthcare through the Continuous Connected […] The post FluidAI Medical Teams Up with Medtronic for Remote Monitoring via...| FluidAI Medical
Each week we highlight five things affecting the life sciences industry. Here’s the latest. ... READ MORE >| The Real Economy Blog
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update.| The Real Economy Blog
Each week we highlight five things affecting the life sciences industry. Here’s the latest.| The Real Economy Blog
Innovation is at the heart of MedTech product development. As medical knowledge progresses and technology advances.| eLeaP®
Mabtech, a biotech company specializing in immunoassays for research and clinical diagnostics, sought to enhance the efficiency, user-friendliness, and accuracy of their key products like the FluoroSpot, ELISpot, and FociSpot readers. These improvements were crucial to strengthen their tools used in vaccine development and disease characterization amidst the global fight against diseases caused by viruses, bacteria, and parasites.| Qamcom
